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ABSTRACT
Objective: Recognising the need for a best-practice
and consistent approach in providing care to women
with rheumatoid arthritis (RA) in relation to (1) general
health, (2) contraception, (3) conception and
pregnancy, (4) breast feeding and (5) early parenting,
we sought to achieve cross-discipline, clinical
consensus on key messages and clinical practice
behaviours in these 5 areas.
Design: 3-round eDelphi study. In round 1, panellists
provided free-text responses to open-ended questions
about care for women with RA across the 5 areas.
Subsequently, panellists refined and scored the
synthesised responses, presented as metathemes,
themes and detailed elements. Where ≥5% of
panellists did not support a theme in a given round,
it was removed.
Setting: Panel of practicing Australian rheumatologists
(n=22), obstetricians/obstetric medicine physicians
(n=9) and pharmacists (n=5).
Results: 34 (94.4%) panellists participated in all 3
rounds. The panel supported 18 themes across the 5
areas (support/strongly support: 88.2–100%)
underpinned by 5 metathemes. Metathemes focused
on coordination in information delivery, the mode and
timing of information delivery, evidence underpinning
information, engagement of the right health
professionals at the right time and a non-judgemental
approach to infant feeding. Themes included practices
for primary prevention of chronic disease and their
sequelae, the importance of contraception and
planning pregnancy and breast feeding, close
monitoring of medications, supporting mental well-
being, managing disease activity and providing
practical support for early parenting.
Conclusions: A cross-disciplinary clinical panel highly
supported key information and clinical practices in the
care for women with RA across the continuum of
contraception to early parenting within a whole-person,
chronic disease management approach.
INTRODUCTION
Rheumatoid arthritis (RA) typically occurs in
women during their childbearing years,1 with
a prevalence that has increased over the last
15 years2 and is expected to increase in
coming decades.3 Compounded with the pros-
pect of living with a chronic, painful and some-
times progressive disease associated with
substantial physical and mental health
impacts,4 young women with RA and their
families face additional challenges in naviga-
ting a safe and successful pathway to parent-
hood.5 Specifically, this pathway requires
informed, collaborative decision-making and
careful planning on the part of the patient
and health professional(s) around RA disease
activity monitoring and safe pharmacological
management, physical and emotional health,
and social support as they relate to contracep-
tion, conception and pregnancy, birth, breast
feeding and early parenting.1 5–10
Strengths and limitations of this study
▪ A clinical panel of rheumatologists, obstetricians
and pharmacists contributed to the development
of the recommendations, reflecting ‘real-world’,
multidisciplinary clinical perspectives on best-
practice care for women with rheumatoid arthritis.
▪ Inductive analysis of responses to open-ended
questions ensured that themes were developed
empirically from the expert panel.
▪ Very strong support was achieved for the final
set of recommendations.
▪ The recommendations relate to clinical best-
practice within a high-income economy and
therefore may not be readily transferable to
middle and low-income economies.
Briggs AM, et al. BMJ Open 2016;6:e012139. doi:10.1136/bmjopen-2016-012139 1
Open Access Research
group.bmj.com on October 31, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Our recent primary research investigating the informa-
tion and service needs of Australian women with RA
concerning pregnancy, breast feeding and early parent-
ing identified a dearth of contemporary information
available to support women to make informed decisions
and implement practical coping strategies.6 In particular,
our data suggest that women with RA have clear
pregnancy-related educational needs and seek specific
information from their care providers about medicines
safety during pregnancy and breast feeding, physical and
emotional support services and practical coping stra-
tegies to manage pain and flares during the postnatal
period.6 Moreover, in a recent systematic review and
editorial, we identified a lack of self-management
interventions for women with RA targeted towards these
issues,9 11 despite European League Against
Rheumatism (EULAR) recommendations that specific
patient education is critical at important life and disease
course stages12 and published Standards of Care for RA
that recommend comprehensive and individually tai-
lored education about RA and its management.13 While
some consumer texts14 15 and arthritis organisation web
pages have been developed to address information gaps
in this area, they remain limited and inadequately
address some of the most important issues raised by
women relating to disease management and medicines
safety during pregnancy and breast feeding.5 6
Consequently, treating health professionals (particularly
rheumatologists) remain the primary communicators of
such information, which is expected by patients6 16 and
entirely appropriate for the majority of cases.12 Given
that patients’ information needs vary,6 highly prescrip-
tive guidelines are unlikely to be of use in clinical prac-
tice and do not align well with a patient-centred model
of care.
Dealing with these issues is complex for health profes-
sionals, particularly in the light of limited data related to
drug safety in pregnancy and breast feeding,1 17 high-
lighting the importance of shared decision-making.
Recent publications, however, provide updated evidence
on medicines safety during pregnancy and breast
feeding.18–20 While these medications safety data and
guidelines are fundamental to optimising clinical prac-
tice, they reflect only one component of care for women
with RA at this important life stage. A broader counsel-
ling approach from health professionals is therefore
important1 10 21 and there is currently limited guidance
in this area.20
Considering that a multidisciplinary approach to care
is most likely to confer optimal fetal and maternal out-
comes,1 cross-discipline communication is important, as
is consistency in the interdisciplinary messages that are
provided to women with RA.1 These issues are particu-
larly relevant in settings with limited specific healthcare
resources.22 The Australian healthcare system supports
interdisciplinary care for people with chronic health
conditions, such as RA. For most patients, care is coordi-
nated by family physicians, and in the context of RA and
pregnancy, is delivered by rheumatologists and obstetri-
cians, and supported by allied health practitioners and
community and hospital pharmacists. Outside public ter-
tiary hospital clinics, these health professionals are
rarely colocated, so coordination of care and communi-
cation between health professionals can be fragmen-
ted.23 Notably, proceedings from the American College
of Rheumatology (ACR) Reproductive Health Summit
suggest that interprofessional and patient–professional
communication in issues relating to fertility, pregnancy
and lactation need to be improved.1 Further, women
with RA have expressed great concern and frustration at
the contradictory messages they receive from their
healthcare providers relating to RA management during
conception, pregnancy, breast feeding and early parent-
ing.6 Having already undertaken primary research to
identify the health information and service needs of
women with RA concerning pregnancy, postnatal care
and early parenting6 and evidence for the effectiveness
of interventions to improve women’s knowledge and self-
management skills related to contraception, pregnancy
and breast feeding;11 our programme of translational
research sought to develop guidance for clinicians in
interprofessional care. Specifically, this study aimed to
establish cross-discipline consensus on the important
educational messages (ie, ‘what to say’) and practice
behaviours (ie, ‘what to do’) in the management of
women with RA relating to contraception, pregnancy,
breast feeding and early parenting.
MATERIALS AND METHODS
Design
An eDelphi process, consisting of three rounds following
standard protocols,24 25 was used to address the research
aim.
Sampling
A multidisciplinary national clinical panel was recruited,
consisting of Australian practising rheumatologists, obste-
tricians/obstetric medicine physicians and pharmacists.
Given our earlier primary research with patients6 and
that the focus of this study was to develop guidance for
clinicians, we did not include patients on the Delphi
panel. Panellists were sampled via a range of strategies,
including self-nomination, purposive sampling via per-
sonal invitation from the researchers and snowballing;
consistent with standard practice and recent Delphi
studies and protocols in rheumatology research.13 20 26–31
The specific sampling strategies used for each discipline
are summarised below:
▸ Rheumatologists: a study flyer was provided to all atten-
dees of the 2015 Australian Rheumatology Association
Annual Scientific Meeting, inviting rheumatologists
who met the inclusion criteria to contact one of the
investigators (SVD) to express their interest in partici-
pating. The same investigator also sent email invita-
tions to rheumatologists in each Australian state and
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territory who were known to the research team to prac-
tice clinically and/or who had an interest in
pregnancy-related care.
▸ Pharmacists: pharmacists known to have a special inter-
est in medicines safety with pregnancy or breast
feeding were invited via email from one of the investi-
gators (SVD) to participate. In addition, pharmacy
departments at two tertiary women’s hospitals
(Victoria and South Australia) and one university
(Western Australia) were contacted to nominate suit-
ably qualified pharmacists to facilitate snowballing.
▸ Obstetricians/Obstetric medicine physicians: clinicians
known to have a special interest in inflammatory arth-
ritis, chronic disease or high-risk pregnancies were
invited to participate via email from one of the inves-
tigators (SVD). Websites of obstetric medicine prac-
tices were searched to identify clinicians who
advertised a special interest in high-risk pregnancies.
Across each of the three disciplines, clinicians were
invited to nominate other colleagues who met the study
inclusion criteria, to facilitate snowballing.
Inclusion criteria for the panellists included: current
registration to practice in Australia; a minimum of
4 years consultant experience (rheumatologists, obstetri-
cians/obstetric medicine physicians) or clinical practice
experience (pharmacists); and currently clinically active
for at least 8 hours (or two clinical sessions) per week or
had undertaken this level of clinical practice within the
last 5 years. All potential panellists were asked to com-
plete an online screening questionnaire that was used to
confirm eligibility and collect demographic data.
eDelphi protocol and analysis
All eDelphi rounds were administered using Qualtrics
software (Provo, Utah, USA). Each round started by
sending panellists an email with a unique hyperlink to
access the portal.
In round 1, panellists were asked to provide free-text
responses to 10 open-ended questions about important
information and resources women with RA and their
families needed to receive across five domains, includ-
ing: (1) general health, (2) contraception, (3) concep-
tion and pregnancy, (4) breast feeding and (5) early
parenting. Free-text data were analysed inductively for
each question using a content analysis approach to
develop a framework of key themes and detailed ele-
ments underpinning each theme within each of the five
domains of interest.32 Overarching metathemes
(guiding principles) were also developed, representing
concepts that spanned across the five domains. Data






n (% panel) 22 (61.1) 9 (25.0) 5 (13.9)
% Female 68.2 77.8 80
Location of practice; n (%)*
Community pharmacy – – 1 (20.0)
Private practice 18 (81.2) 3 (33.3) 1 (20.0)
Public hospital 14 (63.6) 9 (100) 5 (100)
Private hospital 6 (27.3) 2 (22.2) 1 (20.0)
Academic appointment; n (%) 13 (59.1) 7 (77.8) 2 (40.0)
Number of practice locations (median (range)) 2 (1–4) 1 (1–2) 1
Years of consultant/pharmacist experience 15.9 (7.6) 12.3 (7.4) 23.6 (13.1)
Current number weekly clinical sessions (median (IQR))† 7 (3.8) 7 (5.5) n/a
Current weekly clinical hours† 32.8 (12.5) 27.5 (23.7) 35.0 (12.8)
Usual number weekly clinical sessions in last 5 years† (median
(IQR))†
8 (4) 8 (3.5) –
Average weekly clinical hours in last 5 years† 35.7 (12.9) 35.5 (16.8) 37.3 (11.7)
Special interest in inflammatory arthritis; n (%) n/a 3 (33.3) 3 (60.0)
Special interest in rheumatic diseases; n (%) n/a 3 (33.3) 2 (40.0)
Special interest in pregnancy or breast feeding; n (%) 17 (77.3) n/a 4 (80.0)
Discussed contraception, pregnancy, breast feeding or early parenting in the last month; n (%)
0 patients 2 (9.1) n/a 0 (0)
1–3 patients 3 (13.6) n/a 1 (20.0)
4–7 patients 6 (27.3) n/a 1 (20.0)
8–10 patient 7 (31.8) n/a 0 (0)
>10 patients 4 (18.2) n/a 3 (60.0)
Data presented as n (%) for categorical variables and mean (SD) for continuous variables unless otherwise stated.
*Panellists could select more than one option.
†Panellists could respond to clinical hours per week and/or clinical sessions per week.
n/a, not applicable for the respondent.
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were analysed independently by two analysts with clinical
and patient communication expertise (AMB and JEJ,
respectively). Where discrepancies were identified, these
were resolved by consensus and review of the raw data.
In round 2, panellists were presented with a synthesis
of the themes and elements for each domain and asked
to assign their level of agreement with the information
presented. Panellists were asked to rate their agreement
at the key theme level, while being cognizant of the
detailed elements underpinning each theme, using a
three-point Likert scale: ‘completely agree’; ‘partly agree
(modifications required)’; ‘disagree’. Where panellists
selected ‘partly agree’ or ‘disagree’ for a particular
theme, they were asked to provide a free-text response
to explain their selection. Where a theme was scored as
≥5% ‘disagree’ by the panel, it was removed. Free-text
data were analysed as described above and used to
further refine the themes and elements. Elements were
further categorised into clinical practices (‘what to do’)
for health professionals and key messages to be dissemi-
nated (‘what to say’).
In round 3, panellists were presented with a final syn-
thesis of the domain-specific themes and elements relat-
ing to clinical practices and key messages. Panellists
assigned their level of support at the key theme level,
while being cognizant of the detailed elements under-
pinning each theme, using a five-point Likert scale:
‘strongly support’; ‘support’; ‘undecided’; ‘oppose’;
‘strongly oppose’. Panellists were given the opportunity
to provide additional comments using free-text fields for
each of the five domains. Where a key theme was scored
as ≥5% ‘oppose’ or ‘strongly oppose’ by the panel, it was
removed. Free-text data were analysed as described above
and used to further refine the themes and elements.
Descriptive statistics were used to characterise the
panel. All members of the research team reviewed the
synthesised themes and elements at each round for
clarity and clinical meaningfulness. Descriptive statistics
were used to analyse frequency data from rounds 2 and 3.
RESULTS
Thirteen (35.1%) individuals self-nominated, 16
(43.2%) were purposively sampled and a further 8
(21.6%) were identified from snowballing. Of these, 36
(97.3%) were deemed eligible to participate in round 1
(1 was ineligible due to having <4 years consultant
experience). Demographic characteristics of the 36
panellists are summarised in table 1.
Thirty-five panellists (97.2%) participated in round 2
and 34 (94.4%) in round 3.
Analysis of free-text data from round 1 revealed 21
themes, supported by detailed elements across the five
domains. At the second round, two themes exceeded
the inclusion threshold of ≥5% disagreement and were
removed. At the third round, one theme exceeded the
inclusion threshold of ≥5% oppose or strongly oppose,
leaving a final set of 18 themes supported by five
metathemes (guiding principles) with support/strongly
support for key themes ranging from 88.2% to100%.
Metathemes (guiding principles) focused on coordin-
ation in information delivery across health professionals,
the mode and timing of information delivery, evidence
underpinning information, engagement of the right
health professionals at the right time and a non-
judgemental approach to infant feeding approaches
(box 1).
In the final presentation of themes and elements data
for each of the five domains (tables 2–4), the elements
for ‘saying’ and ‘doing’ are not intended to be linked
and interpreted together within a specific table row.
Rather, they should be interpreted independently and as
a non-hierarchical list.
For general health approaches, panellists recom-
mended primary prevention practices for chronic
disease management, discussion around RA manage-
ment and guidance on identifying trustworthy informa-
tion (table 2). Across the four themes, final round
scores for strongly support or support ranged from
94.1% to 100.0%.
For contraception, discussing the importance of
contraception and its various options were identified as
important themes (table 3). Across the two themes, final
Box 1 Metathemes (guiding principles) derived from the
data that spanned all domains of interest
Guiding principles
1. Consistent information should be conveyed to women with
rheumatoid arthritis (RA) by a range of health professionals
across the care continuum in a coordinated manner, based on
the expertise of the health professional and relevance to the
patient (ie, it is not suggested that one health professional
carries the responsibility to convey all this information)
2. The mode and format in which information is delivered;
timing of information; and level of details provided by a health
professional(s) should be tailored to the needs of the patient,
stage of their decision-making and with consideration of their
health literacy, emotional well-being and overall situation at
the time
3. Information provided by health professionals should be based
on the best level of evidence currently available (or best prac-
tice in the absence of clear evidence) and relevant to their
disease status
4. The recommended actions are those that should be under-
taken across the health professional team, in a coordinated
approach if and when appropriate. It is important to recognise
that not all team members will be needed at all times: some
team members will have different roles at different times (eg,
general practitioners and gynaecologists may take a greater
role in counselling about contraception, while rheumatologists
would likely take a greater role in reviewing medication
profiles)
5. Information and actions are intended to support women with
RA who plan to, or choose to, breast feed in a non-
judgemental manner. It is acknowledged that a range of infant
feeding options are available and that breast feeding may not
always be possible
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Table 2 Themes and elements relating to general health information for women with rheumatoid arthritis and their families
Saying: Information that should be discussed by health
professionals
Doing: Actions that should be undertaken by health
professionals
General health and primary prevention practices should be discussed across health providers, inclusive of the need for
appropriate physical activity, nutrition, psychological health and relevant screening practices (100%)
It is important to maintain a healthy weight range through
adequate and appropriate diet and physical activity
Support cessation of smoking (if smoker)
Alcohol intake should be minimised; eg, abide to WHO safe
drinking levels and consume less alcohol than currently
recommended levels for otherwise healthy women
Recommend/refer for screening procedures as appropriate
including: bone mineral density, cardiovascular risk factors,
pap test and breast examination
For some mothers and their families, it is important to
consider mental well-being/stress management strategies
Review immunisation requirements (particularly if on
immunosuppressive drugs) and ensure immunisation profile is
up to date
Safe sexual health practices, including contraception and
sexually transmitted disease prevention, should be adhered to
Referral to appropriate health professionals for further detailed
information where required (eg, contraception counselling)
Specific aspects of RA management should be discussed (as appropriate to patient) relating to medication, contraception and
self-management (100%)
DMARDs have benefit and risk profiles across the course of
the disease. Using DMARDs and other agents to manage
disease activity is critical for maternal and fetal health
Adopt a holistic approach to management of RA (ie,
medication is only one aspect of RA management)
It is important to use reliable contraception when taking
medications that may affect the fetus
Review, discuss and document current medications including:
side effects, interactions, contraindications, effect of
medications on fertility and implantation, timing of withdrawal of
medications in planning pregnancy, need for and timing related
to switching medications
Bone health needs to be monitored and managed in people
with RA
Offer pregnancy test (if any chance of pregnancy) before
starting medications that may affect the fetus
Provide guidance in relation to obtaining relevant and trustworthy information about RA (94.1%)
It is important to learn about RA and its management, but
the use of websites should be limited to those that are
reputable/reliable
Encourage patients to take the time to learn about RA to
optimise their health literacy
It is important to confirm information with a specialist and to
use the internet and discussion forums judiciously
Information about the safety of RA medications, particularly
in relation to pregnancy, may be inconsistent, overly
conservative or potentially out of date (eg, manufacturer
information) and therefore it is important to always check
with a specialist
Discuss the need for family planning and relevant considerations with respect to management of RA and involve partners,
where appropriate (100%)
It is important to plan for pregnancy and the postpartum
period (including breast feeding) with specialists prior to
conception
Establishment of an appropriate multidisciplinary team for RA
management, especially as it relates to pregnancy and early
parenting when required
Have an optimistic outlook—pregnancy and breast feeding
are not contraindicated in RA and can be successful
It is important to have optimal disease control prior to
pregnancy and breast feeding to improve outcomes for the
mother and baby. Uncontrolled disease activity is harmful to
a mother and baby, so appropriate medication management
is critical
There are medication safety issues relating to conception,
pregnancy and breast feeding
Four themes are listed with their supporting elements for ‘saying’ and ‘doing’. The proportion of panellists who supported or strongly supported
each theme is identified in parentheses.
DMARD, disease modifying anti-rheumatic drug; WHO, World Health Organization.
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round scores for strongly support or support ranged
from 97.1% to 100.0%.
For conception and pregnancy, medication reviews,
discussion about maternal and fetal health and precon-
ception care, maintaining optimism, health and disease
monitoring and practical considerations related to being
pregnant with RA were deemed important (table 4).
Across the six themes, final round scores for strongly
support or support ranged from 94.1% to 100.0%.
Similarly, medication reviews and discussion concern-
ing maternal and fetal health were considered important
for breast feeding (table 5). For both of the two themes,
final round scores for strongly support or support were
100.0%.
For early parenting, discussing impacts of RA, medica-
tion reviews and whole-person management were consid-
ered important (table 6). Across the four themes, final
round scores for strongly support or support ranged
from 88.2% to 100.0%.
DISCUSSION
While clinical practice guidelines, drug surveillance data
from registries, databanks and electronic medical
records are critical to informing clinicians’ decisions
about safe and appropriate RA management decisions,33
these resources do not necessarily bridge the ‘know-do’
gap for clinicians or empower patients to engage in
shared decision-making.34 Supporting clinicians with
clinician-centred, practical guidance (eg, guidance on
‘what to say’ and ‘what to do’) on how to practically imple-
ment evidence into routine clinical practice is therefore
important,34 particularly in diseases like RA where evi-
dence–practice gaps exist.35 36 To the best of our knowl-
edge, this is the first study that has addressed this issue
as it relates to cross-discipline management of RA in the
context of contraception, pregnancy, breast feeding and
early parenting. While recent publications provide excel-
lent contemporary evidence on concerning the safety
and effectiveness of pharmacological management in
the perinatal and postnatal periods,18–20 they do not
consider a broader approach to management, particu-
larly as it relates to implementing a person-centred
model of care at the level of the clinical encounter.
Consensus-based recommendations, supported by
metathemes, have been developed to guide information
delivery and clinical practices in a model of person-
centred care for RA. Importantly, this study
Table 3 Themes and elements relating to specific contraception information for women with rheumatoid arthritis and their
families
Saying: Information that should be discussed by health
professionals
Doing: Actions that should be undertaken by health
professionals
Discuss need for, and importance of, contraception (100%)
It is important to use contraception as a strategy to plan
pregnancies and ensure good control of RA prior to
conception, for optimal outcomes
Explore the patient’s current relationship situation—whether
in a relationship, current sexual activity status, plans for
children (soon/later/never) and if currently using
contraception (including what type)
There are possible sequelae if one falls pregnant while on
treatment
Determine need for contraception based on review of current
medications (especially for Methotrexate and Leflunomide);
disease activity and/or washout periods of medication
Develop plan of potential options if unplanned pregnancy
occurs, particularly if on medications which may affect the
fetus, including where to seek expert advice
Outline different contraception options available including discussion of advantages and disadvantages based on patient need
(97.1%)
There are different contraceptive methods available (eg,
barrier, hormonal, IUDs, diaphragms) and these options
should be discussed in detail with your general practitioner in
the first instance
Provide written information regarding contraception options
(where appropriate)
There are pros and cons of different contraception options
relating to efficacy, convenience, cost, risks (eg, infection
concerns with IUDs and comorbidities or medical history) and
physical ability of the patient to insert devices correctly. In
most cases, the general practitioner or gynaecologist is the
most appropriate practitioner to discuss this information.
Where more disease-specific clinical decisions are required,
engagement of rheumatologists may be indicated
Two themes are listed with their supporting elements for ‘saying’ and ‘doing’. The proportion of panellists who supported or strongly supported
each theme is identified in parentheses.
IUD, intra-uterine device.
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Table 4 Themes and elements relating to specific conception and pregnancy information for women with rheumatoid arthritis
and their families
Saying: Information that should be discussed by health
professionals
Doing: Actions that should be undertaken by health
professionals
Review of current medications in relation to safety during conception and pregnancy (100%)
Prior to conception and pregnancy, review current
medication(s) and discuss:
▸ Medications vary with respect to their safety during
pregnancy and risks related to fertility, ovulation, conception
and miscarriage
▸ Some medicines used in RA care may have effects on
fertility, conception and pregnancy process, for example,
regular NSAIDs may impair fertility and associated risks
with fetus
▸ It is important to time conception
Provide guidance as to where to obtain reliable information
about safety of medicines in pregnancy
Where current medication(s) is (are) contraindicated for
conception/pregnancy the following should be discussed with
the patient:
▸ There are safe medication options pre, during (including
delivery) and postpregnancy (including breast feeding)
▸ Timing is important in relation to ceasing or switching of
current medications and allowing for washout periods prior
to conception
▸ There is a need for close supervision/monitoring by a
rheumatologist when discontinuing current medications
prior to pregnancy, including considering potential need for
disease stabilisation on new treatment prior to conception
and pregnancy
Discuss impact of RA pathology on pregnancy and pregnancy on RA (100%)
There are different scenarios regarding RA disease activity
during pregnancy (eg, possible remission/low disease activity)
Discuss: RA-related pain management options during
pregnancy
Conception may take longer compared with women who do
not have RA
There is a need to balance disease control with maternal and
fetal health and safety
RA may affect pregnancy and pregnancy may affect RA, and
there are possible adverse outcomes where risks are identified
(eg, prematurity)
There are significant risks associated with active or
uncontrolled RA for the mother and baby, especially
irreversible joint damage and functional impairment
Pregnancy may change a patient’s health outlook in the future
The size of the baby may be smaller than women without RA
and may also be delivered pre-term
Discuss important elements of preconception care relevant to patient (97.1%)
It is important to achieve optimal disease control prior to
considering pregnancy—planning conception is preferable
after patients achieve and maintain low disease activity
Encourage and facilitate early discussions with all health
practitioners involved in care about family planning to allow
for adequate preparation
There is a critical need for a planned pregnancy rather than an
unplanned pregnancy
Review prenatal nutrition, including need for dietary/vitamin
supplements (ie, folic acid, calcium, vitamin D, iodine, iron)
History of previous attempts to conceive/pregnancies or
pregnancy-related complications (eg, miscarriage) and other
relevant patient history (such as smoking/illicit drug use
history, family history of hereditary issues) may affect
pregnancy
Undertake relevant health checks such as immunisation
status (eg, rubella, varicella, pertussis), sexually transmitted
disease screening, pap test, screening for other autoimmune
disorders that may impact on pregnancy
Weight management and appropriate exercise are very
important
Consider the need for review of diabetes or impaired
glucose tolerance if risk factors are present (eg, on steroid
medication or overweight/obese)
Continued
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complements the eumusc.net standards of care for RA13
and EULAR overarching principles for antirheumatic
drug use before, during and after pregnancy20 by opera-
tionalising these standards and principles in the context
of contraception, pregnancy, breast feeding and early
parenting.
The themes and elements identified across the five
domains reasonably balance clinical practice behaviours
and recommendations for the delivery of health infor-
mation across health professionals with support for self-
management, shared decision-making and recognition
of non-physical impacts of pregnancy and early parent-
ing on a background of RA. We suggest these compo-
nents and this balance are reflective of best practice in a
person-centred model of care for a chronic disease, such
as RA.37 The consensus clinical recommendations also
Table 4 Continued
Saying: Information that should be discussed by health
professionals
Doing: Actions that should be undertaken by health
professionals
It is important to manage comorbid conditions, such as
diabetes and hypertension
Some women may need to avoid conception during a flare
RA disease activity may or may not improve with pregnancy
and there is a likelihood of postpartum flares
Importance of maintaining optimistic outlook and providing positive messages (97.1%)
Pregnancy and breast feeding success rates are near normal
in women with mild to moderate RA nowadays (where
appropriate for the patient’s clinical status)
RA is not a barrier to pregnancy
Strategies to address anxiety, stress and depression (if
relevant) are important, such as mindfulness meditation
Need for close monitoring of a patient prior to and during pregnancy, where indicated (94.1%)
It is importance to have a healthcare team with expertise in
autoimmune disorders for some women with RA
Determine the need for high-level obstetric care during a
pregnancy (where indicated), including the need for
anaesthetic input
Some women require closer monitoring of their pregnancy and
this is usually proportional to disease activity, comorbidities
and maternal history
Assess the requirements for any extra treatment or
monitoring prior to, or during, pregnancy
It is important to develop a pregnancy plan, which includes
different options for management of RA and support for
different scenarios
Vaginal delivery may not always be possible, depending on
condition of the patient’s hips. There are other possible
options for delivery and positions
Outline practical considerations and planning requirements for the patient in relation to pregnancy and postdelivery (94.1%)
Support networks are important during and after pregnancy
(particularly in relation to postnatal flares)
Develop a plan as to how to manage a pregnancy based on
physical function
There are different pain management options for RA disease if
medications are withdrawn during pregnancy
Develop a plan for equipment and services required to care
for an infant
It is important to establish a skilled, general practitioner-led
multidisciplinary team
Develop a postpartum management plan for medicines and
physical therapies
In some situations, clinical psychologists play an important role Assess the need for physiotherapy and occupational therapy
assessment/review and support in terms of managing
physical tasks associated with caring for a baby
There is a need for contraception after delivery if taking
medications that may be harmful to the fetus
Assess physical ability to manage pregnancy, motherhood
and family life
Explore patient’s wishes regarding a birth plan
Explore patient’s breast feeding wishes and potential
considerations for immediately after birth (eg, initial
attachment, establishing lactation) and during postnatal
period (eg, ability to hold baby and feed comfortably)
Six themes are listed with their supporting elements for ‘saying’ and ‘doing’. The proportion of panellists who supported or strongly supported
each theme is identified in parentheses.
NSAID, non-steroidal anti-inflammatory drug.
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align with the findings of a recent review around man-
aging pregnancy in women with rheumatological
disease,38 and extend beyond the physical implications
of RA. Although a previous small study reported no
mental health impact of pregnancy in a group of
women with RA compared with controls, as assessed by
the SF-36,39 panellists in our study recognised the poten-
tial for psychological health to be impacted. The
metathemes acknowledge that these recommendations
should be considered in the context of a person’s health
literacy and disease status, which are critical for
informed decision-making and capacity to engage in
cocare.40 Importantly, many of the themes and elements
were oriented towards empowering women, through tai-
lored education, to make decisions (eg, about breast
feeding) in collaboration with their health professionals
and maintaining a positive outlook to pregnancy and
early parenting. In this context, an important theme
that emerged was the risk of relying on web-based mate-
rials for information about medicines safety related to
pregnancy and breast feeding and disease control.
Panellists were unequivocal in recommending that
women seek professional advice from their healthcare
team and consult appropriately qualified organisations,
Table 5 Themes and elements relating to specific breast feeding information for women with rheumatoid arthritis and their
families
Saying: Information that should be discussed by health
professionals
Doing: Actions that should be undertaken by health
professionals
Discussion of breastfeeding considerations for patient that take into account their disease activity, medication, physical
function and social support network (100%)
Breast feeding is important and highly possible with RA when
planned appropriately
Discuss the patient’s breast feeding considerations that are
tailored to their RA disease activity, medications, physical
function and other comorbidities (eg, osteoporosis) including:
▸ Patient beliefs and wishes
▸ Risks/benefits
▸ Duration
▸ Plan for different options depending on disease control
(including postnatal flares)
There are potential challenges associated with RA and
breast feeding (eg, postnatal flares, being able to hold the
baby comfortably for a prolonged period of time and fatigue)
Refer to local lactation consultant or direct to local
breastfeeding support organisations (eg, breast feeding
associations) for further information and support if required
There are many benefits associated with breast feeding to
the baby and mother
Good disease control is important to optimise duration of
breast feeding
There is a need to balance medication for disease control to
maintain a healthy mother with the importance of breast
feeding
There is often a need for support and help in assisting with
breast feeding, caring for the baby and getting adequate rest
Review of RA medication in relation to safety during breast feeding once pregnancy has been established (100%)
Some medications can be safely continued while breast
feeding (eg, most biologics) and some that are
contraindicated (eg, Methotrexate)
Provide guidance concerning misinformation about drugs, eg,
awareness of no official rating system for safety of drugs in
lactation unlike in pregnancy, and need to consult beyond
product information provided by pharmaceutical companies
(ie, consult with health professionals)
Timing breast feeding around drug administration to minimise
exposure to the baby can be important, especially where
medication has a short half-life
Identify/refer to credible sources for obtaining information
about medication in lactation
Breast feeding may need to be stopped if disease activity
cannot be brought under control
Provide information relating to expressing breast milk, storage
and feeding to assist with management of medication regimes
There are different medication options that can assist with
establishing lactation (where problems are experienced) that
are also safe with RA medication
Develop an individualised breast feeding plan based on
identified risk factors (eg, diabetes, non-vaginal birth, ability to
hold infant comfortably) prior to birth. Review and modify the
plan regularly, particularly in the early postpartum period until
breast feeding is established
It is imperative to review breastfeeding practices if
medications change
Two themes are listed with their supporting elements for ‘saying’ and ‘doing’. The proportion of panellists who supported or strongly supported
each theme is identified in parentheses.
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Table 6 Themes and elements relating to specific early parenting information for women with rheumatoid arthritis and their
families
Saying: Information that should be discussed by health
professionals
Doing: Actions that should be undertaken by health
professionals
Discuss potential impacts of RA in early parenting (91.2%)
Possible impacts of RA include greater fatigue, pain levels,
joint deformities and musculoskeletal dysfunction/mobility
impairment. These may impact on one’s ability to undertake
specific tasks when caring for a baby
There is a possibility of RA flares during the postnatal period.
It is important to contact your rheumatologist early to discuss
management options if flares occur
Sleep deprivation increases the risk of higher disease activity
and pain
Physical limitations may impact parenting of children
It is important to learn pacing and balance activity with rest
Consider the long-term risks and challenges associated with
early parenting in the context of having RA
With good planning and consideration, women with RA are
able to have a similar experience to other parents who do not
live with RA
Review RA medication options during the postpartum period (100.0%)
There are substantial benefits in achieving good disease
control for mother and baby postpartum and this may need to
be a primary aim
Provide treatment options/develop a plan to manage flares if
they arise (eg, ability to safely use NSAIDs, Prednisolone,
Plaquenil and Salazopyrin if breast feeding)
It is important to continue treatment compliance even though
your normal routine will be altered
Review medication options after breast feeding has ceased
Discuss the potential impact/safety of RA medications on the
baby, for example, anti-TNF medications given in pregnancy
Discuss physical and psychological support needs during early parenting (88.2%)
There is often a need for support networks, given the
challenges associated with early parenting such as sleep
deprivation and physical impairments. Mothers groups and
RA peer support groups may be useful options to consider
Refer to occupational therapy/physiotherapy for assistance
with physical tasks associated with caring for baby
Direct to local arthritis organisation for further information and
support
Develop an action plan for support including when to seek
help and who to contact
Discuss practical advice about caring for an infant (eg,
accessing a cot, pushing a pram, changing nappies) and the
importance of occupational therapy and physiotherapy
support
Importance of maintaining well-being and disease control (94.1%)
It is important to maintain a healthy lifestyle, for example,
healthy diet, safe exercise, alcohol and smoking restrictions/
modifications
Discuss the childhood vaccination schedule and relevant
safety considerations including:
▸ Some childhood vaccinations are live and care needs to
be taken if on standard or biological DMARDs
▸ Vaccinations required/contraindicated based on RA drugs
transmitted to baby
Refer to appropriate specialists for further information, for
example, paediatricians or neonatal medicine specialists
Good disease control is important for bone health
Four themes are listed with their supporting elements for ‘saying’ and ‘doing’. The proportion of panellists who supported or strongly supported
each theme is identified in parentheses.
DMARD, disease modifying anti-rheumatic drug; NSAID, non-steroidal anti-inflammatory drug; TNF, tumour necrosis factor.
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such as arthritis consumer organisations and breast
feeding organisations, for more information. Notably,
while internet searching is important to consumers in
this context,6 41 data from recent studies examining
website quality as it relates to chronic pain suggest it is
highly variable.42 43
Panellists provided the most detailed responses for
Theme 3—Conception and Pregnancy. In addition to
supporting women in conception and pregnancy within
a chronic disease model of care through education,
practical skills and situation planning, the most signifi-
cant clinical issues raised related to the critical need for
pregnancy planning due to the possible teratogenic
effects of disease-modifying agents and achieving disease
control to ensure maternal and fetal health and safety.
These issues are consistent with those raised in recent
reviews on this topic, confirming face validity of the
recommendations20 22 38 and reflect the priorities of
women with RA.6 We suggest, therefore, that our find-
ings, while intentionally clinician-centred, align well with
the primary research we conducted with women with RA
that formed the basis for the current study.6
Panellists considered that assessment of indications
and contraindications for various contraceptive options
related predominantly to care provided by general prac-
titioners or gynaecologists and this theme was, therefore,
not included in the final set. Notably, a recent systematic
review44 and guidelines45 have been published on the
issue of contraception in RA, which provides some guid-
ance to clinicians.
While recommendations have been developed
concerning the management of RA at this important life
stage,18–20 38 44 45 there is a lack of RA-specific guidelines
for clinicians, largely attributed to a lack of definitive
clinical trials data concerning drug toxicity and safety
during pregnancy and breast feeding, particularly as they
relate to the newer disease-modifying agents.10 A recent
review highlights this issue to be particularly relevant in
the Middle East.22 Variability in practice is, therefore,
unsurprising,46 resulting in uncertainty and dissatisfac-
tion for patients.6 47 Our data offer some practical strat-
egies for health professionals as a means to facilitate
consistency in an approach to management and a
prompt for cross-discipline care, which has previously
been identified as inadequate,47 despite being recom-
mended.38 For women with RA and their families, we
support the use of the RA Standards of Care Checklist as
a means to ensure RA care, as it relates to contraception,
pregnancy, breast feeding and early parenting, is
optimised.13
Our study has a number of important strengths: we
recruited a large expert sample relative to other compar-
able studies in arthritis care,12 13 20 27 30 31 our sample was
cross-disciplinary with a spread of practice locations across
the country, our response rate remained very high across
all three rounds, and we achieved a high level of support
for the final set of themes. Our sample was purposely
weighted towards rheumatologists to reflect the discipline
most usually involved across the continuum of care from
contraception through to early parenting. Importantly,
however, the findings do not relate solely to
rheumatologist-delivered care, but rather all clinicians
involved in a woman’s care and reflect a best-practice
approach. It would be unreasonable to expect a single clin-
ician or clinical discipline to adopt all the recommenda-
tions. The transferability of our recommendations may be
limited in some aspects since we sampled only Australian
clinicians and therefore, the cross-cultural relevance and
meaningful transferability to other health systems (eg,
those in low and middle-income economies or rural set-
tings) should be explored in future work.22 48 Australians
living in urban settings enjoy a health system that supports
access to coordinated care from multiple health profes-
sionals. In rural Australia and in other nations, this is
rarely accessible and therefore the recommendation to
establish multidisciplinary care teams may not be feasible
in a real-world setting in these contexts, particularly at the
primary care level. Multidisciplinary team care may, in
some settings, be more appropriately established at the ter-
tiary hospital level where access to medical specialists and
upskilled allied health providers is more achievable.
Although we did not include patients in our sample, the
foci for the Delphi were directly informed by previous
empirical, consumer-based research, consistent with the
approach adopted by Hawker et al.30 The results from this
study and our recent systematic review11 point to the
opportunity to develop and evaluate targeted educational
interventions for this group of consumers.
CONCLUSION
Coordinated, multidisciplinary care for women with RA
concerning contraception, pregnancy, breast feeding
and early parenting is important. Although clinical
guidelines provide necessary information on ‘what care’
should be provided, guidance on ‘how’ to provide the
care is rarely described. Cross-discipline recommenda-
tions for care delivery include: counselling and practices
relating to primary prevention of chronic disease and
their sequelae, supporting women to actively use contra-
ception and to plan pregnancy and breast feeding, close
monitoring of medications, supporting mental well-
being, managing disease activity and providing practical
support for early parenting. A chronic disease model of
care should underpin these practices.
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